December 2023 - Page 2 of 3 - BioMedWire (BMW)

MondayDec 18, 2023 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Fireside Chat with CEO Howard Weisman Sheds Light on Company Achievements for ASD Therapy Pipeline

The CDC estimates 1 out of 36 children in the United States have been diagnosed with Autism Spectrum Disorder – with a therapeutic market potential of $3.42 billion by 2030 PaxMedica’s mission is to help eliminate, reduce, or modulate the troublesome aspects of ASD, an unmet medical need in the industry CEO Howard Weisman shared important updates and achievements in the company’s pipeline, financial outlook, and future vision In a 2020 report released by the Centers for Disease Control and Prevention (“CDC”), it was estimated that 1 out of 36 children had been diagnosed with autism spectrum disorder (“ASD”) in…

FridayDec 15, 2023 10:46 am

Researchers Discuss How Brain Cancer Radiotherapy Side Effects Can Be Reduced

A group of researchers recently convened at an event organized by the John B. Little (JBL) Center for Radiation Sciences to discuss strategies for mitigating the side effects of brain cancer radiotherapy. Radiation therapy is one of the core pillars of brain-cancer treatment alongside chemotherapy and surgery. The noninvasive treatment involves using beams of intense energy such as X-rays or other particles to destroy cancer cells and shrink tumors. Radiation therapy is used to treat many types of cancers and contributes to at least 40% of all cancer treatments worldwide, making it an integral tool in the fight against cancer.…

FridayDec 15, 2023 9:45 am

SOHM Inc. (SHMN) Releases New Product Line and Expands Manufacturing Operations in Carlsbad, California

SOHM is launching a line of 13 new chewables that offer a range of health benefits and expand the company's preventative care product portfolio The new line will be available online through Amazon.com and the company's direct-to-consumer website and will be showcased at industry conferences in 2024 SOHM is addressing its increased product demand by establishing a new CDMO GMP manufacturing facility in Carlsbad, California The new manufacturing facility is expected to be open by the end of 2023, and shareholders will be updated about its operations during its year-end 2023 report SOHM (OTC: SHMN), a pharmaceutical, nutraceutical, and cosmeceutical…

ThursdayDec 14, 2023 11:24 am

Senate Committee Hears How Drug Shortages Impact Patients

A Senate Committee meeting has revealed that experts are worried about the impact of critical drug shortages on the American public. Anderson Cancer Center’s Lymphoma Clinical Research program director Dr. Jason Westin recently testified before the U.S. Senate Committee on Finance and told committee members that the United States is facing a shortage of generic cancer drugs. Westin said generic cancer drugs have been instrumental in saving the lives of many cancer patients, but the country is currently facing a shortage of these critical drugs. He told committee members the shortage is putting him and his patients in an terrible…

WednesdayDec 13, 2023 11:41 am

Chinese Researchers Notch Major Milestone in Developing Gene Editing System Against Autism

Chinese researchers may have scored a major win in the fight against autism after they successfully edited a mutated gene associated with autism in mice. The research team developed a genome-editing system capable of treating ASD-related mutations in mice using base editing in the brain. This treatment represents the first-ever injection with the ability to reverse autism symptoms, at least in mouse models, and could open the door to the development of alternative treatments for other neurodevelopmental disorders. The injection corrects mutations in the MEF2C gene, which typically occur in patients with autism spectrum disorder (ASD). Estimates from the United…

WednesdayDec 13, 2023 9:00 am

SOHM Inc.’s (SHMN) New Gene-Editing Technology Holds Potential to Revolutionize the Field of Cardiology, With Superior Capabilities Over Other Gene-Editing Systems

SOHM recently acquired ABBIE, a world-class gene-editing platform capable of inserting larger DNA sequences, including full genes, into a desired location of the target cell’s genome ABBIE is poised to facilitate drug development, with SOHM confident that its new gene-editing technology can revolutionize the field of cardiology by supporting new ways of discovering and developing drugs The ABBIE platform system is easy to operate and boasts high efficiency, low cost, and simple design ABBIE improves on some of the shortcomings of CRISPR-Cas9 as well as other gene-editing technologies, such as enabling researchers to edit genes of a large number of…

TuesdayDec 12, 2023 9:00 am

Smart Trackers Could Detect Aging-Related Complications in Seniors

Wearable smart devices that track daily circadian rest-activity rhythms may allow for the detection of frailty-related health risks in seniors more than six years before the problems occur. A new study from Harvard-affiliated Brigham and Women’s Hospital has found that smart trackers could aid in the prediction of age-related health risks long before incidents happen. Older populations tend to face age-related declines in their psychological functions as they grow older, especially individuals who are genetically predisposed to develop certain age-related psychological conditions. In most cases, however, these conditions often become apparent once the illness has set in and symptoms have…

MondayDec 11, 2023 11:15 am

SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement

SOHM, a generic drug manufacturing and distributing innovator, announced its development collaboration with the University of Arizona Center for Innovation (“UACI”) for the advancement of its ABBIE platform In the arrangement, SOHM will establish offices and a wet lab bench, taking advantage of UACI’s robust and specialized infrastructure SOHM’s management is optimistic about the collaboration and is confident that this is but the first step toward deepening new lab operations It also marks a significant milestone, as it anticipates monetizing ABBIE off-the-shelf, non-viral gene editing kits SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, just announced its development…

MondayDec 11, 2023 9:45 am

Stem Cell Therapy Shows Promise in Halting Progression of Cognitive Decline in MS Patients

A team of researchers from Italy’s Hospital Casa Solleivo della Sofferenza, the University of Milan Bicocca and the University of Cambridge have discovered that stem cell therapy may be effective at slowing the progression of cognitive decline in patients with multiple sclerosis (MS). MS is a debilitating neurological disorder that occurs when the immune system becomes dysfunctional and begins attacking the protective covering around nerve fibers. There are four types of MS, with two of them being progressive. That means their symptoms become more and more severe over time, causing the patient’s disability to worsen as the disease progresses. Around…

MondayDec 11, 2023 9:00 am

Astrotech Corp. (NASDAQ: ASTC) Is ‘One to Watch’

In November 2023, the company announced a purchase order from a Romanian company for seven TRACER 1000 ETDs to be deployed in a European airport Astrotech announced in June 2023 that its board unanimously rejected an unsolicited acquisition proposal from BML Investment Partners In May 2023, the company announced a purchase order from a Romanian company for 17 TRACER 1000 ETDs, to be delivered during calendar 2023 Astrotech confirmed test results from field trials of the AgLAB 1000-D2 mass spectrometer for hemp and cannabis producers, improving yields by an average of 24% In December 2022, the company effected a 1-for-30…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Month: December 2023

PaxMedica Inc. (NASDAQ: PXMD) Fireside Chat with CEO Howard Weisman Sheds Light on Company Achievements for ASD Therapy Pipeline

Researchers Discuss How Brain Cancer Radiotherapy Side Effects Can Be Reduced

SOHM Inc. (SHMN) Releases New Product Line and Expands Manufacturing Operations in Carlsbad, California

Senate Committee Hears How Drug Shortages Impact Patients

Chinese Researchers Notch Major Milestone in Developing Gene Editing System Against Autism

SOHM Inc.’s (SHMN) New Gene-Editing Technology Holds Potential to Revolutionize the Field of Cardiology, With Superior Capabilities Over Other Gene-Editing Systems

Smart Trackers Could Detect Aging-Related Complications in Seniors

SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement

Stem Cell Therapy Shows Promise in Halting Progression of Cognitive Decline in MS Patients

Astrotech Corp. (NASDAQ: ASTC) Is ‘One to Watch’

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search